The new facility, which will more than double the current facility, is expected to get completed in 2012.
The fill/finish suites will feature automated vial and syringe filling, inspection and labeling equipment capable of producing batch sizes of 100,000 plus units.
Pii senior vice president Steve King said the additional facilities will enable them to support their clients from pre-clinical through commercial-scale production.
"The additional facilities will meet the growing demand for fill/finish services for potent compounds and oncology drugs," King added.
"Pii has demonstrated its expertise in sterile product development and aseptic manufacturing, offering our clients a quality product with strict adherence to regulatory compliance standards."